Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05414331 · ClinicalTrials.gov registry record · NA
WithDRawal Impact Of Postoperative Beta-Blocker
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT05414331 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 43 participants.
The verdict
NCT05414331, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The investigators will evaluate the impact of withdrawing beta-blocker medication after coronary artery bypass surgery with this randomized controlled trial.
Interventions
- OTHER Discontinuing all beta-blocker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2022-11-04 |
| Est. Completion | 2024-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05414331
The ClinicalTrials.gov registry entry for NCT05414331 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Discontinuing all beta-blocker is the first listed.
NCT05414331 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05414331 about?
NCT05414331 is a clinical study titled "WithDRawal Impact Of Postoperative Beta-Blocker". The investigators will evaluate the impact of withdrawing beta-blocker medication after coronary artery bypass surgery with this randomized controlled trial.
What is the current status of trial NCT05414331?
This trial is currently terminated. It is a NA study. The enrollment target is 43 participants. The study started on 2022-11-04. Estimated completion is 2024-05-30.
What interventions are being tested in trial NCT05414331?
The interventions under investigation include: Discontinuing all beta-blocker (OTHER).
Who is sponsoring clinical trial NCT05414331?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.